[Comparative study of the anti-influenzal effectiveness of bonafton, oxoline, florenal and rimantadine].
D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use* / Q000633:toxicity; D001952:Bridged-Ring Compounds / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005449:Fluorenes / Q000627:therapeutic use*; D006037:Glyoxal / Q000031:analogs & derivatives / Q000627:therapeutic use; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009281:Naphthalenes / Q000627:therapeutic use*; D009285:Naphthoquinones / Q000627:therapeutic use*; D009976:Orthomyxoviridae Infections / Q000188:drug therapy*; D013764:Tetrahydronaphthalenes; D013997:Time Factors
D000998:Antiviral Agents; D001952:Bridged-Ring Compounds; D005449:Fluorenes; D009281:Naphthalenes; D009285:Naphthoquinones; D013764:Tetrahydronaphthalenes; C003020:oxoline; D006037:Glyoxal; D000218:Adamantane
Sravnitel'noe izuchenie protivogrippoznoĭ éffektivnosti bonaftona, oksolina, florenalia i rimantadina.